Onconetix, Inc.

Onconetix, Inc.

Biotechnology • Healthcare • Cincinnati, OH, United States • ONCO (NCM)

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

513 620 4101 201 East Fifth Street, Cincinnati, OH 45202, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Aug Patterns: Why ONCO stock is trending among retail traders - July 2025 Review & Breakout Confirmation Trade Signals - moha.gov.vn
moha.gov.vn • Dec 29
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders - Business Wire
Business Wire • Jul 16
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders - Yahoo Finance
Yahoo Finance • Jun 11
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewswire
GlobeNewswire • Sep 26
Breaking: $2.1B Biotech Merger Collapses - Onconetix and Ocuvex Part Ways as Ocuvex Preps Drug Launch - Stock Titan
Stock Titan • Sep 26

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Onconetix, Inc. had layoffs?
No layoff events have been recorded for Onconetix, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Onconetix, Inc. have?
Onconetix, Inc. has approximately 5 employees.
What industry is Onconetix, Inc. in?
Onconetix, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Onconetix, Inc. a publicly traded company?
Yes, Onconetix, Inc. is publicly traded under the ticker symbol ONCO on the NCM. The company has a market capitalization of approximately $0.00 billion.
Where is Onconetix, Inc. headquartered?
Onconetix, Inc. is headquartered in Cincinnati, OH, United States at 201 East Fifth Street, Cincinnati, OH 45202, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.